High mobility group box 1 complexed with heparin induced angiogenesis in a matrigel plug assay.
暂无分享,去创建一个
[1] N. Van Rooijen,et al. Extratumoral macrophages promote tumor and vascular growth in an orthotopic rat prostate tumor model. , 2009, Neoplasia.
[2] E. Ruokonen,et al. HMGB1 as a predictor of organ dysfunction and outcome in patients with severe sepsis , 2008, Intensive Care Medicine.
[3] S. Sela,et al. Are primed polymorphonuclear leukocytes contributors to the high heparanase levels in hemodialysis patients? , 2008, American journal of physiology. Heart and circulatory physiology.
[4] T. Yoshino,et al. Anti‐high mobility group box 1 monoclonal antibody ameliorates brain infarction induced by transient ischemia in rats , 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[5] A. Maseri,et al. Smooth muscle cells in human atherosclerotic plaques secrete and proliferate in response to high mobility group box 1 protein , 2006, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[6] K. Tracey,et al. HMGB1 SIGNALS THROUGH TOLL-LIKE RECEPTOR (TLR) 4 AND TLR2 , 2006, Shock.
[7] M. Presta. Response to Comment on “Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine” , 2006, The Journal of Immunology.
[8] M. Presta,et al. Cutting Edge: Extracellular High Mobility Group Box-1 Protein Is a Proangiogenic Cytokine1 , 2006, The Journal of Immunology.
[9] P. Rogalla,et al. Angiogenetic signaling through hypoxia: HMGB1: an angiogenetic switch molecule. , 2005, The American journal of pathology.
[10] Bart Landuyt,et al. Vascular Endothelial Growth Factor and Angiogenesis , 2004, Pharmacological Reviews.
[11] K. Tracey,et al. Recombinant HMGB1 with cytokine-stimulating activity. , 2004, Journal of immunological methods.
[12] M. Flugelman,et al. Heparanase Induces Endothelial Cell Migration via Protein Kinase B/Akt Activation* , 2004, Journal of Biological Chemistry.
[13] F. Yuan,et al. Evidence for Involvement of HMGB1 Protein in Human DNA Mismatch Repair* , 2004, Journal of Biological Chemistry.
[14] T. Sasahira,et al. Depletion of Tumor-Infiltrating Macrophages Is Associated with Amphoterin Expression in Colon Cancer , 2004, Pathobiology.
[15] M. Bianchi,et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation , 2004, The Journal of cell biology.
[16] H. Kuniyasu,et al. Differential effects between amphoterin and advanced glycation end products on colon cancer cells , 2003, International journal of cancer.
[17] Hoguen Kim,et al. Overexpression of high mobility group box 1 in gastrointestinal stromal tumors with KIT mutation. , 2003, Cancer research.
[18] M. Yamakuchi,et al. High mobility group box chromosomal protein 1 plays a role in the pathogenesis of rheumatoid arthritis as a novel cytokine. , 2003, Arthritis and rheumatism.
[19] K. Tracey,et al. Activation of gene expression in human neutrophils by high mobility group box 1 protein. , 2003, American journal of physiology. Cell physiology.
[20] K. Tracey,et al. HMGB1 B box increases the permeability of Caco-2 enterocytic monolayers and impairs intestinal barrier function in mice. , 2002, Gastroenterology.
[21] A. Ridley,et al. Receptor for advanced glycation end products-binding COOH-terminal motif of amphoterin inhibits invasive migration and metastasis. , 2002, Cancer research.
[22] T. Misteli,et al. Release of chromatin protein HMGB1 by necrotic cells triggers inflammation , 2002, Nature.
[23] K. Tracey,et al. HMGB1 as a late mediator of lethal systemic inflammation. , 2001, American journal of respiratory and critical care medicine.
[24] M. Kaksonen,et al. Heparin-binding proteins HB-GAM (pleiotrophin) and amphoterin in the regulation of cell motility. , 2000, Matrix biology : journal of the International Society for Matrix Biology.
[25] K. Tracey,et al. High Mobility Group 1 Protein (Hmg-1) Stimulates Proinflammatory Cytokine Synthesis in Human Monocytes , 2000, The Journal of experimental medicine.
[26] T. Kislinger,et al. Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases , 2000, Nature.
[27] Michael Bustin,et al. Regulation of DNA-Dependent Activities by the Functional Motifs of the High-Mobility-Group Chromosomal Proteins , 1999, Molecular and Cellular Biology.
[28] K. Tracey,et al. HMG-1 as a late mediator of endotoxin lethality in mice. , 1999, Science.
[29] M. Schachner,et al. High Affinity Binding and Overlapping Localization of Neurocan and Phosphacan/Protein-tyrosine Phosphatase-ζ/β with Tenascin-R, Amphoterin, and the Heparin-binding Growth-associated Molecule* , 1998, The Journal of Biological Chemistry.
[30] N. Yoshimura,et al. Tranilast inhibits the proliferation, chemotaxis and tube formation of human microvascular endothelial cells in vitro and angiogenesis in vivo , 1997, British journal of pharmacology.
[31] T. Shono,et al. Involvement of interleukin-8, vascular endothelial growth factor, and basic fibroblast growth factor in tumor necrosis factor alpha-dependent angiogenesis , 1997, Molecular and cellular biology.
[32] K. Sugimachi,et al. Enhanced coexpression of thioredoxin and high mobility group protein 1 genes in human hepatocellular carcinoma and the possible association with decreased sensitivity to cisplatin. , 1996, Cancer research.
[33] G. Camussi,et al. Tumor necrosis factor alpha-induced angiogenesis depends on in situ platelet-activating factor biosynthesis , 1994, The Journal of experimental medicine.
[34] H. Rauvala,et al. Amphoterin, the 30-kDa protein in a family of HMG1-type polypeptides. Enhanced expression in transformed cells, leading edge localization, and interactions with plasminogen activation. , 1993, The Journal of biological chemistry.
[35] A. Logan,et al. Angiogenesis , 1993, The Lancet.
[36] Wagner V. Yotov,et al. Nucleotide sequence of a mouse cDNA encoding the nonhistone chromosomal high mobility group protein-1 (HMG1) , 1992, Nucleic Acids Res..
[37] P. Colville-Nash,et al. Angiogenesis and rheumatoid arthritis: pathogenic and therapeutic implications. , 1992, Annals of the rheumatic diseases.
[38] H. Rauvala,et al. Neurite growth-promoting protein (amphoterin, p30) binds syndecan. , 1992, Experimental cell research.
[39] G. Laurie,et al. Basement membrane complexes with biological activity. , 1986, Biochemistry.
[40] E. Mayes,et al. The primary structures of non‐histone chromosomal proteins HMG 1 and 2 , 1980, FEBS letters.
[41] H. Towbin,et al. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. , 1979, Proceedings of the National Academy of Sciences of the United States of America.
[42] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[43] Arjan W. Griffioen,et al. Convergence and amplification of toll-like receptor (TLR) and receptor for advanced glycation end products (RAGE) signaling pathways via high mobility group B1 (HMGB1) , 2008, Angiogenesis.
[44] S. Yamada,et al. HMGB1, a novel inflammatory cytokine. , 2007, Clinica chimica acta; international journal of clinical chemistry.
[45] M. Nishibori,et al. Mast cell tryptase stimulates DLD-1 carcinoma through prostaglandin- and MAP kinase-dependent manners. , 2005, Journal of pharmacological sciences.
[46] S. Toda,et al. Mast cells and angiogenesis , 2003, Microscopy research and technique.
[47] J. Parkkinen,et al. Amphoterin, the 30-kDa Protein in a Family of HMGl-type Polypeptides , 2001 .
[48] A. Passaniti,et al. A simple, quantitative method for assessing angiogenesis and antiangiogenic agents using reconstituted basement membrane, heparin, and fibroblast growth factor. , 1992, Laboratory investigation; a journal of technical methods and pathology.
[49] H. Shepard,et al. Macrophage-induced angiogenesis is mediated by tumour necrosis factor-α , 1987, Nature.